PAHC PHIBRO ANIMAL HEALTH CORP revenue, earnings and financials
For the quarter ended March 31, 2026, PHIBRO ANIMAL HEALTH CORP reported revenue of $384M (up 10.3% from a year earlier), net income of $24.0M and diluted EPS of $0.59; over the last four quarters revenue was $1.50B and net income $95.2M; for the fiscal year ended June 2025 revenue was $1.30B, up 27.4% on the year before.
PAHC annual revenue and earnings
- Fiscal year ended Jun 2025: revenue $1.30B, gross profit $400M, operating income $110M, net income $48.3M (margin 3.7%), EPS $1.19
- Fiscal year ended Jun 2024: revenue $1.02B, gross profit $313M, operating income $53.3M, net income $2.42M (margin 0.2%), EPS $0.06
- Fiscal year ended Jun 2023: revenue $978M, gross profit $298M, operating income $71.8M, net income $32.6M (margin 3.3%), EPS $0.81
- Fiscal year ended Jun 2022: revenue $942M, gross profit $285M, operating income $79.0M, net income $49.2M (margin 5.2%), EPS $1.21
- Fiscal year ended Jun 2021: revenue $833M, gross profit $271M, operating income $74.9M, net income $54.4M (margin 6.5%), EPS $1.34
PAHC quarterly revenue and earnings
- Quarter ended Mar 31, 2026: revenue $384M (up 10.3% year over year), net income $24.0M, EPS $0.59
- Quarter ended Dec 31, 2025: revenue $374M (up 20.9% year over year), net income $27.5M, EPS $0.67
- Quarter ended Sep 30, 2025: revenue $364M (up 39.7% year over year), net income $26.5M, EPS $0.65
- Quarter ended Jun 30, 2025 (from the annual report): revenue $379M (up 38.6% year over year), net income $17.2M, EPS $0.43
- Quarter ended Mar 31, 2025: revenue $348M (up 32.1% year over year), net income $20.9M, EPS $0.51
- Quarter ended Dec 31, 2024: revenue $309M (up 23.7% year over year), net income $3.19M, EPS $0.08
- Quarter ended Sep 30, 2024: revenue $260M (up 12.6% year over year), net income $6.98M, EPS $0.17
- Quarter ended Jun 30, 2024 (from the annual report): revenue $273M (up 7.1% year over year), net income $752K, EPS $0.02
- Quarter ended Mar 31, 2024: revenue $263M (up 7.1% year over year), net income $8.41M, EPS $0.21
- Quarter ended Dec 31, 2023: revenue $250M (up 2.2% year over year), net income $1.27M, EPS $0.03
- Quarter ended Sep 30, 2023: revenue $231M (down 0.5% year over year), net income −$8.02M, EPS −$0.20
- Quarter ended Jun 30, 2023 (from the annual report): revenue $255M (down 0.1% year over year), net income $11.5M, EPS $0.28
- Quarter ended Mar 31, 2023: revenue $246M (up 2.5% year over year), net income $10.0M, EPS $0.25
- Quarter ended Dec 31, 2022: revenue $245M (up 5.1% year over year), net income $7.21M, EPS $0.18
- Quarter ended Sep 30, 2022: revenue $233M (up 8.3% year over year), net income $3.86M, EPS $0.10
- Quarter ended Jun 30, 2022 (from the annual report): revenue $255M, net income $7.49M, EPS $0.18
- Quarter ended Mar 31, 2022: revenue $240M (up 13.2% year over year), net income $17.7M, EPS $0.44
- Quarter ended Dec 31, 2021: revenue $233M, net income $17.5M, EPS $0.43
- Quarter ended Sep 30, 2021: revenue $215M, net income $6.53M, EPS $0.16
- Quarter ended Mar 31, 2021: revenue $212M, net income $12.2M, EPS $0.30
PAHC cash flow, buybacks and dividends
- Fiscal year ended Jun 2025: operating cash flow $80.1M, share buybacks n/a, dividends $0.48 per share
- Fiscal year ended Jun 2024: operating cash flow $87.6M, share buybacks n/a, dividends $0.48 per share
- Fiscal year ended Jun 2023: operating cash flow $13.3M, share buybacks n/a, dividends $0.48 per share
- Fiscal year ended Jun 2022: operating cash flow $31.6M, share buybacks n/a, dividends $0.48 per share
- Fiscal year ended Jun 2021: operating cash flow $48.3M, share buybacks n/a, dividends $0.48 per share
PAHC balance sheet
- Jun 30, 2026: cash $61.4M, total assets $1.50B, total liabilities $1.12B, shareholders' equity $385M
- Mar 31, 2026: cash $54.9M, total assets $1.45B, total liabilities $1.08B, shareholders' equity $362M, long-term debt $598M
- Dec 31, 2025: cash $55.5M, total assets $1.41B, total liabilities $1.07B, shareholders' equity $332M, long-term debt $604M
- Sep 30, 2025: cash $72.8M, total assets $1.39B, total liabilities $1.07B, shareholders' equity $312M, long-term debt $610M
- Jun 30, 2025: cash $68.0M, total assets $1.36B, total liabilities $1.08B, shareholders' equity $286M, long-term debt $615M
- Mar 31, 2025: cash $60.4M, total assets $1.32B, total liabilities $1.05B, shareholders' equity $266M, long-term debt $619M
- Dec 31, 2024: cash $67.1M, total assets $1.29B, total liabilities $1.04B, shareholders' equity $247M, long-term debt $623M
- Sep 30, 2024: cash $51.8M, total assets $966M, total liabilities $708M, shareholders' equity $259M, long-term debt $288M
What is PAHC's revenue?
PHIBRO ANIMAL HEALTH CORP reported $1.50B of revenue over its last four quarters, through March 31, 2026.
Is PAHC profitable?
Yes. PHIBRO ANIMAL HEALTH CORP earned $95.2M over the last four quarters.
What is PAHC's EPS?
Diluted earnings per share over the last four quarters were $2.34; $0.59 in the latest quarter.
Does PAHC pay a dividend?
PHIBRO ANIMAL HEALTH CORP paid $0.48 per share in dividends in the fiscal year ended June 2025.